19May 2022
Contemporary Concise Review 2021: Pulmonary nodules from detection to intervention

Contemporary Concise Review 2021: Pulmonary nodules from detection to intervention

The US Preventive Task Force (USPSTF) has updated screening criteria by expanding the age range and reducing the smoking history required for eligibility; the International Lung Screen Trial (ILST) data have shown that PLCOM2012 performs better for eligibility than USPSTF criteria. Screening adherence is low and depends upon multiple systems and patient/candidate‐related factors. COVID‐19 affects lung cancer treatment and screening through delays and disruptions; specific operational challenges need to be met. Over 70% of suspected malignant lesions develop in the periphery of the lungs. Bronchoscopic navigational techniques have been steadily improving to allow greater accuracy with target lesion approximation and diagnostic yield.

  • #pulmonology

Like

Save

Share